FI47573C - Process for the preparation of -fluoro-11,21-dihydroxy-16,17 (2-propenylidenedioxy) -p Regna-1,4-diene-3,20-dione and its 21-esters. - Google Patents

Process for the preparation of -fluoro-11,21-dihydroxy-16,17 (2-propenylidenedioxy) -p Regna-1,4-diene-3,20-dione and its 21-esters.

Info

Publication number
FI47573C
FI47573C FI58970A FI58970A FI47573C FI 47573 C FI47573 C FI 47573C FI 58970 A FI58970 A FI 58970A FI 58970 A FI58970 A FI 58970A FI 47573 C FI47573 C FI 47573C
Authority
FI
Finland
Prior art keywords
propenylidenedioxy
regna
dione
dihydroxy
diene
Prior art date
Application number
FI58970A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI47573B (en
Inventor
Boissier
Ratouis
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR6906348A external-priority patent/FR2035766A1/en
Priority claimed from FR6938912A external-priority patent/FR2068427A1/en
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI47573B publication Critical patent/FI47573B/fi
Application granted granted Critical
Publication of FI47573C publication Critical patent/FI47573C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI58970A 1969-03-07 1970-03-04 Process for the preparation of -fluoro-11,21-dihydroxy-16,17 (2-propenylidenedioxy) -p Regna-1,4-diene-3,20-dione and its 21-esters. FI47573C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR6906348A FR2035766A1 (en) 1969-03-07 1969-03-07 Preparation of prenane derivs
FR6938912A FR2068427A1 (en) 1969-11-13 1969-11-13 Preparation of prenane derivs

Publications (2)

Publication Number Publication Date
FI47573B FI47573B (en) 1973-10-01
FI47573C true FI47573C (en) 1974-01-10

Family

ID=26214890

Family Applications (1)

Application Number Title Priority Date Filing Date
FI58970A FI47573C (en) 1969-03-07 1970-03-04 Process for the preparation of -fluoro-11,21-dihydroxy-16,17 (2-propenylidenedioxy) -p Regna-1,4-diene-3,20-dione and its 21-esters.

Country Status (9)

Country Link
JP (1) JPS4843910B1 (en)
BE (1) BE746965A (en)
DK (1) DK122812B (en)
ES (1) ES376421A1 (en)
FI (1) FI47573C (en)
GB (1) GB1292269A (en)
NL (1) NL7001308A (en)
NO (1) NO134746C (en)
SE (1) SE360652B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200108002A (en) * 2018-01-08 2020-09-16 리제너론 파마슈티칼스 인코포레이티드 Steroids and antibody-conjugates thereof

Also Published As

Publication number Publication date
FI47573B (en) 1973-10-01
SE360652B (en) 1973-10-01
GB1292269A (en) 1972-10-11
NO134746C (en) 1976-12-08
JPS4843910B1 (en) 1973-12-21
DE2006635A1 (en) 1970-09-24
NO134746B (en) 1976-08-30
ES376421A1 (en) 1972-04-16
DK122812B (en) 1972-04-17
BE746965A (en) 1970-09-07
NL7001308A (en) 1970-09-09

Similar Documents

Publication Publication Date Title
NL166694C (en) PROCESS FOR THE PREPARATION OF 16BETA-METHYL-9ALFA-FLUOR-11BETA, 17ALFA, 21-TRIHYDROXY-1,4-PREGNADIENE -3,20-DION AND ITS 21-ACYLATES.
DK129039B (en) Process for the preparation of 11β, 16α17α21-tetrahydroxy-pregna-1,4-diene-3,20-diones or the corresponding 16,17-acetonides.
FI47573C (en) Process for the preparation of -fluoro-11,21-dihydroxy-16,17 (2-propenylidenedioxy) -p Regna-1,4-diene-3,20-dione and its 21-esters.
DK122454B (en) Process for the preparation of 9α, 21,21-trichloro-11β-fluoro-pregn-4-ene-3,20-diones.
DK133382B (en) Analogous process for the preparation of 6alpha, 9alpha-difluor-11beta, 17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17,21-diacetate.
DK126937B (en) Process for the preparation of 4,6-dihalo-16-alkylidene-17α-hydroxy-pregna-4,6-diene-3,20-diones.
DK124539B (en) Process for the preparation of 6-hydroxy-3-keto-Δ <1,4> steroids of the pregnane or androstane series.
FI46952C (en) Process for the preparation of 6alpha-fluoro-9alpha, 11beta, 21-trihalogen-1,4-pregnadiene-3,20-dione derivatives
AU3608271A (en) New 6&-fluoro-16&-18-dimethyl-^1,4-pregnadiene-3,20-diones
FI46505C (en) Process for the preparation of therapeutically useful 6alpha, 9alpha, 2-trihalogen-16alpha-methyl-11beta-hydroxy-1,4-pregnadiene-3,20-diones.
DK132121B (en) Process for the preparation of 17alpha-hydroxypregna-4,9 (11) -diene-3,20-dione.
DK128208B (en) Process for the preparation of 1,4-diensteroids of the androstane or pregnane series with unsubstituted 3-position.
IL34227A (en) Process for the preparation of 17alpha-propadienyl steroids and new 6,6-difluoro-17alpha-propadienyl-17beta-hydroxy-delta4 estrenes and androstenes
FI49159C (en) Process for the preparation of 9alpha-halogen-6alpha, 16alpha-dimethyl-1,4 -pregnadiene-3,20-dione derivatives.
CA779285A (en) 1,2.alpha.-METHYLENE STEROIDS OF THE PREGNANE SERIES AND PROCESS FOR THEIR MANUFACTURE
CA813895A (en) 9.alpha.-CHLORO-11.beta.-HYDROXY-16.beta.-METHYL-17.alpha.,21-DIPROPIONYLOXYPREGNA 1,4-DIENE-3,20-DIONE
DK131787B (en) Analogous process for the preparation of 2-chloro-delta-1,4-pregnadiene-3,20-diones.
FI47483C (en) Process for the preparation of 6alpha-fluoro-9alpha-21-dihalo-11beta-hydroxy-16-methyl-1,4-pregnadiene 3,20-diones
CA743941A (en) PROCESS FOR THE PREPARATION OF 6,17.alpha.-DIMETHYL-4,6-PREGNADIENE-3,20-DIONE
CA695204A (en) 17.alpha.-ACYLOXY-6.alpha.-METHYLPREGN-4-ENE-3:20-DIONES AND PROCESS FOR THEIR PREPARATION
CA781457A (en) 7.alpha.,17,17-TRIMETHYL-3-ENE STEROIDS OF THE ANDROSTANE AND 19-NORANDROSTANE SERIES AND PROCESS FOR THEIR PREPARATION
CA742208A (en) 17-MONOESTERS OF 17.alpha.,21-DIHYDROXY STEROIDS AND PROCESS FOR THE PREPARATION THEREOF
DK128897B (en) Analogous process for the preparation of 2,9α, -11β-trichloro-6α-fluoro-16α-methyl-Δ <1,4> -pregnadiene-17α, 21-diol-3,20-dione or esters thereof.
CA804595A (en) 5.beta.-H-6-KETO STEROIDS AND PROCESS FOR THE MANUFACTURE THEREOF
DK130646B (en) Analogous process for the preparation of 17- and / or 21-alkanoyloxy-11beta-chloro-16beta-methylpregna-1,4-diene-3,20-diones.